市场调查报告书
商品编码
1617143
Peri -到 2030 年的植体炎治疗市场预测:按治疗类型、原因类型、植入类型、设备类型、最终用户和地区进行的全球分析Peri-Implantitis Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type (Non-Surgical Treatments, Surgical Treatments, Combination Treatments and Other Treatment Types), Cause Type, Implant Type, Device Type, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球植体植入炎治疗市场规模为 11 亿美元,预计预测期内复合年增长率为 10.7%,到 2030 年将达到 21 亿美元。
植体周围植入的治疗包括控制植入周围的发炎和感染。治疗选择取决于症状的严重程度,但通常包括非手术方法,例如机械清洗和消毒清洗以减少细菌负荷。更严重的病例需要手术干预,例如皮瓣手术,以进入和清洗更深的区域。抗生素和适当的口腔卫生对于预防復发和长期植入成功至关重要。
根据 NCBI 的数据,在美国平均 2 年追踪期间,患者层面的植入周围炎盛行率为 34.0%,植入层面的盛行率为 21%。
增加植入的使用
人工植牙使用的增加极大地推动了市场的发展。随着越来越多的人选择人工植牙来替代牙齿,对常见併发症植体周围植入的有效治疗的需求不断增长。因此,诊断技术和治疗方案的进步,包括非手术干预和微创手术,正在推动市场成长。对长期植入成功的关注进一步增加了对专门植体周围植入治疗的需求。
缺乏熟练的专家
市面上缺乏熟练的专家会对患者的治疗结果和整体治疗效果产生负面影响。由于专业知识有限,植入的诊断和治疗可能会延迟或不充分,从而导致更高的植入失败率和更长的恢復时间。这种短缺也阻碍了技术创新,限制了先进治疗的获得,并增加了现有专家的负担,导致等待时间更长和治疗可用性降低。
民众口腔卫生意识
民众对口腔卫生意识的提高正在对市场产生正面影响。随着越来越多的人意识到口腔卫生的重要性,尤其是植入周围的口腔卫生,预防植体周围植入已成为人们关注的焦点。关于适当护理、卫生习惯和早期发现的教育宣传活动有助于改善植体周围植入的预防和管理。这种意识的提高推动了对有效治疗方案的需求,并促进了长期植入的成功。
治疗费用高
市面上高昂的治疗费用是许多患者治疗的主要障碍。先进的手术,包括外科手术和专门治疗,通常需要昂贵的设备和专业知识,这增加了成本。这种经济负担限制了患者获得所需治疗的机会,并可能导致他们的医疗状况恶化和植入失败。结果,治疗被推迟或放弃,导致长期健康併发症恶化并增加整体医疗费用。
COVID-19 大流行导致选择性牙科手术(包括植入相关治疗)的延误,并严重扰乱了植体周围植入的治疗市场。锁门和保持社交距离的措施导致就诊人数减少、人员短缺以及对紧急护理的关注,从而延迟了植体周围植入的诊断和治疗。此外,财务不安全和对非必要服务的限制导致成本增加和获得专门护理的机会有限,影响整体治疗结果。
预计钛植入市场在预测期内将成为最大的市场
由于人工植牙的普及,钛植入预计将在预测期内占据最大的市场占有率。钛的生物相容性和耐腐蚀性使其成为植入的首选材料。植入设计、表面改性和治疗方法的进步正在推动市场扩张,重点是提高长期植入成功率并减少感染和骨质流失等併发症。
牙科诊所预计在预测期内复合年增长率最高
预计牙科诊所产业在预测期内将呈现最高的复合年增长率。牙科诊所越来越多地采用先进的诊断工具和治疗技术,例如雷射疗法、抗菌药物和再生手术,来控制植体周围植入。人们对植入失败风险的认识不断提高,以及对有效干预措施的需求不断增加,这推动了对这些环境下专门治疗的需求,从而推动了市场的成长。
由于人工植牙数量的增加,预计北美地区在预测期内将占据最大的市场占有率。雷射疗法和再生技术等诊断和治疗技术的进步正在推动市场发展。该地区完善的医疗保健基础设施可支援市场扩张以及对牙科治疗服务的高需求,使该地区成为植体周围植入治疗创新的关键中心。
由于口腔健康问题日益严重、意识不断提高以及支持性医疗保健政策,亚太地区预计将在预测期内实现最高成长率。该地区的龋齿和牙周病患病率高得惊人,尤其是老年人。提高口腔卫生意识对于推动植体周围植入治疗的需求至关重要。此外,有利的政府政策和医疗基础设施的进步也有助于市场扩张。
According to Stratistics MRC, the Global Peri-Implantitis Treatment Market is accounted for $1.1 billion in 2024 and is expected to reach $2.1 billion by 2030 growing at a CAGR of 10.7% during the forecast period. Peri-implantitis treatment involves managing inflammation and infection around a dental implant, typically affecting the tissues surrounding the implant. Treatment options vary depending on the severity of the condition but often include non-surgical methods like mechanical debridement (cleaning) and antiseptic rinses to reduce bacterial load. In more severe cases, surgical interventions such as flap surgery may be necessary to access and clean deeper areas. Antibiotics and proper oral hygiene are essential for preventing recurrence and ensuring long-term implant success.
According to NCBI, the prevalence of peri-implantitis was 34.0% on the patient level and 21% on the implant level over an average follow-up of 2 years in the U.S.
Increasing usage of dental implants
The increasing use of dental implants has significantly boosted the market. As more people opt for dental implants for tooth replacement, the demand for effective treatments for peri-implantitis, a common complication, rises. This has led to advancements in diagnostic techniques and therapeutic options, including non-surgical interventions and minimally invasive procedures, driving growth in the market. The focus on long-term implant success further enhances the demand for specialized peri-implantitis treatments.
Shortage of skilled specialists
The shortage of skilled specialists in the market negatively impacts patient outcomes and the overall effectiveness of treatments. With limited expertise, the diagnosis and management of peri-implantitis may be delayed or inadequate, leading to higher failure rates of implants and prolonged recovery times. This shortage also hampers innovation, restricts access to advanced care, and increases the burden on existing specialists, resulting in longer waiting times and reduced treatment availability.
Public awareness of oral hygiene
Rising public awareness of oral hygiene has positively impacted the market. As more individuals recognize the importance of maintaining oral health, especially around dental implants, there is an increased focus on preventing peri-implantitis. Educational campaigns on proper care, hygiene practices, and early detection contribute to better prevention and management of the condition. This growing awareness drives demand for effective treatment options and promotes long-term implant success.
High treatment costs
High treatment costs in the market pose a significant barrier to access for many patients. The advanced procedures, including surgical interventions and specialized care, often require expensive equipment and expertise, driving up costs. This financial burden can limit patient access to necessary treatments, potentially leading to worsened conditions or implant failure. As a result, individuals may delay or forgo treatment, exacerbating long-term health complications and increasing overall healthcare costs.
The COVID-19 pandemic significantly disrupted the peri-implantitis treatment market by causing delays in elective dental procedures, including implant-related treatments. Lockdowns and social distancing measures led to reduced patient visits, staff shortages, and a focus on urgent care, slowing down the diagnosis and management of peri-implantitis. Additionally, financial uncertainties and restrictions on non-essential services led to increased costs and limited access to specialized care, affecting overall treatment outcomes.
The titanium implants segment is expected to be the largest during the forecast period
The titanium implants segment is expected to account for the largest market share during the projection period due to the increasing prevalence of dental implant procedures. Titanium's biocompatibility and resistance to corrosion make it a preferred material for implants. Advancements in implant design, surface modifications, and therapeutic approaches are driving market expansion, with a focus on improving long-term implant success rates and reducing complications such as infection and bone loss.
The dental clinics segment is expected to have the highest CAGR during the forecast period
The dental clinics segment is expected to have the highest CAGR during the extrapolated period. Dental clinics are increasingly adopting advanced diagnostic tools and treatment techniques, including laser therapy, antimicrobial agents, and regenerative procedures, to manage peri-implantitis. The growing awareness of implant failure risks and the need for effective interventions are driving demand for specialized treatments in these settings, fostering market growth.
North America region is estimated to account for the largest market share during the forecast period due to the rising number of dental implants. Advances in diagnostic and therapeutic technologies, including laser treatments and regenerative techniques, are driving the market. The region's well-established healthcare infrastructure, along with a high demand for dental care services, supports the market's expansion, positioning the region as a key hub for peri-implantitis treatment innovations.
Asia Pacific is expected to register the highest growth rate over the forecast period driven by increasing oral health issues, rising awareness, and supportive healthcare policies. The prevalence of dental caries and periodontal disease is alarmingly high in the region, particularly among older adults. There is a growing awareness regarding oral health, which is crucial for driving demand for peri-implantitis treatments. Moreover, Favorable government policies and advancements in healthcare infrastructure are also contributing to market expansion.
Key players in the market
Some of the key players in Peri-Implantitis Treatment market include Pfizer Inc., Cadila Pharmaceuticals, R N. Laboratories, Triveni Chemicals, Arthrex, Zimmer Biomet Dental, Stryker, Smith & Nephew, Danaher, 3M, Meyer Dental Laboratory, Cochlear Limited, Medtronic, Bicon Dental Implants, Cendres+Metaux, Straumann AG and Fotona.
In July 2024, Fotona announced the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. Designed to support all Fotona users and practitioners, the new center aims to enhance knowledge, foster collaboration, and achieve clinical excellence.
In February 2024, Straumann has announced the complete acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge has developed an innovative approach to support peri-implantitis treatment, with its CE-marked device launched in 2020.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.